Replimune Group, Inc.
NASDAQ:REPLBiotechnology
Healthcare
$19.81 +1.85%
+$0.19 today
- Market cap
- $1.88B
- Beta
- 0.91
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$3.42
52W Low $1.50High $13.24
Volume 2.13M
Average 7.51M
News
For Replimune Group, Inc., read summarized stories built from several publishers and recent headlines with links to the original coverage.
Stories
All market newsNo stories for REPL yet. A story appears once at least three publishers cover the same event.
More headlines
Recent coverage that has not been summarized. Links open the publisher's site.
- Wall Street Analysts Think Replimune Group (REPL) Could Surge 29.51%: Read This Before Placing a Bet
Zacks Investment Research
Continue the stock analysis
Jump to another research area for this company.